APA (7th ed.) Citation

S, A. I., S, Y., IO, K., T, K., E, B., E, A., . . . M, B. (2026). Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study. Journal of clinical medicine, 15(13), . https://doi.org/10.3390/jcm15134880

Chicago Style (17th ed.) Citation

S, Atas Ipek, et al. "Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study." Journal of Clinical Medicine 15, no. 13 (2026). https://doi.org/10.3390/jcm15134880.

MLA (9th ed.) Citation

S, Atas Ipek, et al. "Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study." Journal of Clinical Medicine, vol. 15, no. 13, 2026, https://doi.org/10.3390/jcm15134880.